PHP
NEPH icon

Parkman Healthcare Partners’s Nephros NEPH Stock Holding History

Parkman Healthcare Partners’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-167,048
Closed -$1.43M – 93
2020
Q4 		$1.43M Sell
167,048
-74,363
-31% -$502K 0.37% 68
2020
Q3 		$1.75M Sell
241,411
-9,955
-4% -$72.8K 0.46% 62
2020
Q2 		$2.11M Hold
251,366
– – 0.59% 55
2020
Q1 		$1.58M Buy
251,366
+51,642
+26% +$438K 0.73% 45
2019
Q4 		$1.99M Buy
+199,724
New +$1.78M 0.57% 51

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Parkman Healthcare Partners's NEPH Position: Q1 2021 in Review

Parkman Healthcare Partners sold out of Nephros (NEPH) in Q1 2021, closing a stake of 167,048 shares — an estimated $1.43M sold.

Parkman Healthcare Partners first reported a position in NEPH in Q4 2019 and held it in 5 quarters. The position peaked at $2.11M in Q2 2020. 21 funds tracked by Wall St. Rank hold NEPH as of Q1 2021.

  • Parkman Healthcare Partners reported no remaining Nephros position as of Q1 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 167,048 Nephros shares in Q1 2021, an estimated $1.43M.
  • Parkman Healthcare Partners first reported a position in Nephros in Q4 2019 and held it in 5 quarters.
  • Parkman Healthcare Partners's Nephros position peaked at $2.11M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Nephros as of Q1 2021.

Based on Parkman Healthcare Partners's 13F filing for Q1 2021, filed 14 May 2021.